# FDA 483 - Nanova Biomaterials Inc - February 14, 2025

Source: https://www.globalkeysolutions.net/records/483/nanova-biomaterials-inc/455b2b41-8812-4ee9-b5b3-da85bc57cba0

> FDA 483 for Nanova Biomaterials Inc on February 14, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Nanova Biomaterials Inc
- Inspection Date: 2025-02-14
- Product Type: drugs
- Office Name: Kansas City District Office
- Summary: An FDA inspection of Nanova Biomaterials Inc in Columbia, MO, from February 11-14, 2025, identified a significant deficiency in equipment calibration procedures. The firm was found to have used expired fluoride standards to verify the 5% fluoride content of its Sodium Fluoride Varnish, affecting products manufactured and sold since November 2022. This indicates a lapse in quality control and compliance with manufacturing standards.

## Related Officers

- [Clifford F. Long](https://www.globalkeysolutions.net/people/clifford-f-long/846e5a0c-cb7c-421c-86aa-be9fddfbaaba)

Company: https://www.globalkeysolutions.net/companies/nanova-biomaterials-inc/01c88cc2-db44-4bf8-8c77-8581d172aa0f

Office: https://www.globalkeysolutions.net/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79